Company intelligence / Profile preview

BIOCAD

Saint Petersburg / Strelna district, Leningrad Oblast, Russia

Ownership: Private
Employees: ~2600
Development stage: Other

Overview

BIOCAD has over 60 medical products on the market with more than 40 additional candidates at various stages of development. Its portfolio includes both original biologics and biosimilars for oncology and autoimmune indications. Key assets such as Netakimab are marketed for ankylosing spondylitis and plaque psoriasis. Pembrolizumab biosimilar is in Phase I for solid tumors. The company also develops mRNA vaccines against infectious diseases like COVID-19

Therapeutic areas: Infectious DiseasesImmunologyOncology
Modalities: Monoclonal antibodies (mAbs)biosimilarssmall moleculesmRNA vaccines
Industry: Biotech

Drug pipeline

34 assets

prolgolimab

33 more assets in the full pipeline.

Request access →

Partnerships

Shanghai Pharmaceuticals Holding Co., Ltd. ("SPH") joint venture for clinical trials/manufacturing in China.Collaborations with healthcare facilities approved by Russian Ministry of Health or international regulators.

Beyond the preview

Go deeper on BIOCAD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOCAD.

Explore the full profile